Manufactured Product (MP) (English, French, CSV)
Manufactured Product (MP): English/French CSV file you can open as a table, filter, chart and export up to 10,000 rows. From Health Canada, updated Jul 2024.
- Format
- CSV
- Access
- Table on demand (prepared when opened)
- Publisher-reported update
- 2024-07-05
The Canadian Clinical Drug Dataset is a drug terminology and coding system designed to allow the interchange of standardized drug and medical device information between diverse digital health systems. Some use cases include electronic prescribing, electronic medical records, medication reconciliation and analytics. It also provides for the classification and identification of defined groups of medications (called special groupings), such as narcotic and controlled drugs. It has the capacity to be used by knowledge-based vendors, clinicians, researchers, statistical users, government agencies, healthcare organisations and consumers. The data source for the CCDD is the Drug Product Database (DPD) which contains information on drugs approved by Health Canada. However, the data is modeled differently following the CCDD Editorial Guidelines which take into consideration international terminology standards. For example, DPD uses the dosage form, “tablet (delayed-release)”, whereas CCDD uses the equivalent term “gastro-resistant tablet.” The Canadian Clinical Drug Data Set does not replace the Health Canada Drug Product Database (DPD) but is published in addition to it. The scope of…
Data overview
- Formats
- CSV
- File languages
- English, French
- Available actions
- Explore table (prepared automatically) · Access original file
Sample rows
The first 10 rows, as CanQuery read them from the start of the publisher's file on 2026-11-03.
| mp_code | mp_formal_name | mp_en_description | mp_fr_description | mp_status | mp_status_effective_time | mp_type | Health_Canada_identifier | Health_Canada_product_name |
|---|---|---|---|---|---|---|---|---|
| 02566273 | IDENOS (denosumab 120 mg per 1.7 mL solution for injection vial) APOTEX INC | NA | IDENOS (dénosumab 120 mg par 1,7 mL solution injectable fiole) APOTEX INC | Active | 20260908 | DIN | 02566273 | IDENOS |
| 02566540 | STEQEYMA (ustekinumab 90 mg per 1 mL solution for injection pen) CELLTRION INC. | NA | STEQEYMA (ustékinumab 90 mg par 1 mL solution injectable stylo) CELLTRION INC. | Active | 20260813 | DIN | 02566540 | STEQEYMA |
| 77701214 | SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) DR REDDY'S LABORATORIES LTD | NA | SUGAMMADEX INJECTION (sugammadex (sugammadex sodique) 200 mg par 2 mL solution injectable fiole) DR REDDY'S LABORATORIES LTD | Active | 20260910 | CCDD | 02532700 | SUGAMMADEX INJECTION |
| 77701215 | SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) DR REDDY'S LABORATORIES LTD | NA | SUGAMMADEX INJECTION (sugammadex (sugammadex sodique) 500 mg par 5 mL solution injectable fiole) DR REDDY'S LABORATORIES LTD | Active | 20260910 | CCDD | 02532700 | SUGAMMADEX INJECTION |
| 02566265 | DENOZA (denosumab 60 mg per 1 mL solution for injection syringe) APOTEX INC | NA | DENOZA (dénosumab 60 mg par 1 mL solution injectable seringue) APOTEX INC | Active | 20260824 | DIN | 02566265 | DENOZA |
| 02563045 | EYDENZELT (aflibercept 2 mg per 0.05 mL solution for injection syringe) CELLTRION INC. | NA | EYDENZELT (aflibercept 2 mg par 0,05 mL solution injectable seringue) CELLTRION INC. | Active | 20260811 | DIN | 02563045 | EYDENZELT |
| 02569140 | RYBREVANT SC (amivantamab 1600 mg per 10 mL solution for injection vial) JANSSEN INC | NA | RYBREVANT SC (amivantamab 1600 mg par 10 mL solution injectable fiole) JANSSEN INC | Active | 20260724 | DIN | 02569140 | RYBREVANT SC |
| 02569159 | RYBREVANT SC (amivantamab 2240 mg per 14 mL solution for injection vial) JANSSEN INC | NA | RYBREVANT SC (amivantamab 2240 mg par 14 mL solution injectable fiole) JANSSEN INC | Active | 20260724 | DIN | 02569159 | RYBREVANT SC |
| 02569167 | RYBREVANT SC (amivantamab 2400 mg per 15 mL solution for injection vial) JANSSEN INC | NA | RYBREVANT SC (amivantamab 2400 mg par 15 mL solution injectable fiole) JANSSEN INC | Active | 20260724 | DIN | 02569167 | RYBREVANT SC |
| 02569175 | RYBREVANT SC (amivantamab 3520 mg per 22 mL solution for injection vial) JANSSEN INC | NA | RYBREVANT SC (amivantamab 3520 mg par 22 mL solution injectable fiole) JANSSEN INC | Active | 20260724 | DIN | 02569175 | RYBREVANT SC |